Muscular dystrophy (MD) is a group of genetic diseases involving progressive weakness and degeneration of the muscles that control movement. In some forms of MD, the heart muscles and other involuntary muscles, as well as other organs, are also affected. There are nine distinct types of MD. Myotonic MD is the most common form among adults, while Duchenne MD is the most common form among children (it affects only boys). MD is an incurable, often fatal disease.
Myotonic muscular dystrophy (which affects adults) is accompanied by the following signs and symptoms:
Although Duchenne MD is present at birth, signs and symptoms do not usually appear until the child is 3 - 5 years of age. They include the following.
Breathing difficulties and a chronic disorder of heart muscles develop during adolescence, usually after the individual becomes wheelchair-bound.
MD is caused by gene mutations that are particular to each form of the disease.
In two-thirds of cases of MD, the person has a family history. In one-third of cases, there is no family history.
If you or someone you take care of has symptoms of MD, you should see your health care provider. Diagnosis depends on sophisticated testing, such as lab tests, imaging, and other procedures.
|
The goal of a treatment plan is to maintain the person's optimal physical and emotional health by preventing joint and spinal deformities. This prolongs the ability to walk for as long as possible. Assisted breathing is introduced as needed, and lifelong physiotherapy is necessary. Orthopedic devices may be needed for support. Hydrotherapy, such as continuous tub baths, may help maintain a full range of joint motion.
|
Your health care provider may prescribe the following medications:
|
Surgery sometimes can help people who have MD.
|
A comprehensive treatment plan for MD may include a range of complementary and alternative therapies.
Following these nutritional tips may help reduce symptoms:
You may address nutritional deficiencies with the following supplements:
Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to get your problem diagnosed before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, you should make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.
Few studies have examined the effectiveness of specific homeopathic remedies. A professional homeopath, however, may recommend one or more of the following treatments for muscular dystrophy based on his or her knowledge and clinical experience. Before prescribing a remedy, homeopaths take into account a person's constitutional type -- your physical, emotional, and intellectual makeup. An experienced homeopath assesses all of these factors when determining the most appropriate remedy for a particular individual.
Regular massage is important for reducing spasm and muscle contractions.
The outlook for people with MD varies, depending on the type and severity of the disease. In mild cases, the disease may progress slowly, and the person may have a normal lifespan. In more severe cases, there is a more marked progression of muscle weakness, functional disability, and loss of ability to get around. Duchenne MD patients usually live into their 20s, and myotonic MD patients usually live into their 40s or 50s. In most cases, individuals with MD die of infections, respiratory problems, or cardiac failure.
MD patients annually undergo electrocardiography, pulmonary function studies, and chest radiographs, along with tests to monitor their swallowing function.
Adams RD, et al. Principles of Neurology . 6 th ed. New York, NY: McGraw-Hill; 1997: 1414–1429.
Bartram T. Encyclopedia of Herbal Medicine . Dorset, England: Grace Publishers; 1995:301.
Berthillier G, Eichenberger D, Carrier HN, et al. Carnitine metabolism in early stages of Duchenne muscular dystrophy. Clin Chim Acta . 1982;122(3):369-75
Dorchies OM, Wagner S, Vuadens O, et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol . 2006;290(2):C616-25.
Edstrom L. Dystrophia myotonica: clinical pathophysiological, and molecular aspects. Scand J Rehab Med Suppl . 1999; 39: 47–52.
Escolar DM, Buyse G, Henricson E, et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol . 2005;58(1):151-5.
Fauci AS, et al. Harrison's Principles of Internal Medicine . 14 th ed. New York, NY: McGraw-Hill; 1998: 2473–2477.
Forst J, Forst R. Lower limb surgery in Duchenne muscular dystrophy. Neuromuscul Disord . December 9, 1999: 176–181.
Gaby AR. The role of coenzyme Q10 in clinical medicine: Part 1. Alt Med Rev . 1996; 1(1):11-17.
Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci . 2006;78(8):803-11.
Jonas WB, Jacobs J. Healing with Homeopathy: The Doctors' Guide. New York, NY: Warner Books; 1996: 261.
Kakulas BA. Problems and solutions in the rehabilitation of patients with progressive muscular dystrophy. Scand J Rehab Med Suppl . 1999; 39: 23-37.
Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res . 2006;20(5):424-5.
Kroksmark A-K. Physiotherapy in muscular dystrophy. Scand J Rehab Med Suppl . 1999; 39: 65-68.
Leger P, Leger SS. Respiratory concerns in Duchenne muscular dystrophy. Pediatr Pulmonology. 1997; 16 (suppl): 137–139.
Motlagh B, MacDonald JR, Tarnoplosky MA. Nutritional inadequacy in adults with muscular dystrophy. Muscle Nerve . 2005;31(6):713-8.
[No authors listed]. L-theanine . Monograph. Altern Med Rev . 2005;10(2):136-8.
Perkin GD, Murray-Lyon I. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry . 1998;65(3):291-300.
Shen DG, Araki M, Higuchi I, et al. The effect of DDB on dystrophic hamsters: an in vivo and in vitro study. Muscle Nerve.1987;10(5):391-6.
Samuels MA, Feske S. Office Practice of Neurology . New York, NY: Churchill Livingstone; 1996; 577–587.
Simon RP, et al. Clinical Neurology . 4 th ed. Stamford, CT: Appleton & Langel; 1999: 189–192.
Stewart PM, Walser M, Drachman DB. Branched chain keto-acids reduce muscle protein degradation in Duchennes muscular dystrophy. Muscle Nerve . 1982; (3): 197-201.
Tarnopolsky M. Creatine Monohydrate increases strength in patients with neuromuscular disease. Neurology . 1999, (52): 854-857.
Toscano A, Messina S, Campo GM, et al. Oxidative stress in myotonic dystrophy type 1. Free Radic Res . 2005;39(7):771-6.
Ullman D. Homeopathic Medicine for Children and Infants. New York, NY: Penguin Putnam; 1992: 115, 217.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |